M

MGX

Metagenomi Therapeutics, Inc

1.360

+0.010+0.74%
After Hours: 1.360  0.000  0.00%16:10 05/26 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.330/1.360
TODAY RANGE1.310-1.420
VOL240.84K
MARKET CAP52.33M
52 WEEK RANGE1.240-3.950
AVG VOL (3M)211.26K
% TURNOVER0.64%
TURNOVER--
P/E (TTM)-0.6053
% RANGE8.09%
EPS(TTM)-2.2965
P/E(FORWARD)-0.6588
P/B0.3798
BVPS3.660
DIVIDEND--
P/S2.074
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP42.25M
SHARES OUTSTANDING37.65M
NEXT EARNINGS08/10-08/14
FREE FLOAT30.40M
LOT SIZE1
EX-DATE--
Same Industry
Name/Symbol
Change%
Price

再生元製藥

REGN

-0.58%
638.88

G

GridAI Tech

GRDX

+4.99%
4.840

B

BIONTECH

BNTX

+1.33%
92.14

聯合治療

UTHR

+1.18%
575.14

福泰製藥

VRTX

+0.23%
434.52

S

SIGA科技

SIGA

-0.64%
4.680

M

Moderna

MRNA

-0.80%
46.88

CRL

--

M

Medpace控股

MEDP

+0.63%
432.80

T

Talphera Inc

TLPH

-0.32%
0.8151

I

ICON PLC

ICLR

+0.18%
116.78

泰邦生物

CBPO

0.00%
119.99

I

Iqvia Hldgs Inc

IQV

-0.07%
167.90

M

MOLECULAR PARTNERS AG

MOLN

+10.00%
4.180

A

Arcturus醫療

ARCT

+0.14%
7.03

吉利德科學

GILD

+2.96%
134.36

P

PRA健康科學

PRAH

0.00%
165.21

因塞特醫療

INCY

-0.26%
97.16

APVO

--

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.